233 related articles for article (PubMed ID: 20368345)
1. The C-terminal tail of Yersinia pseudotuberculosis YopM is critical for interacting with RSK1 and for virulence.
McCoy MW; Marré ML; Lesser CF; Mecsas J
Infect Immun; 2010 Jun; 78(6):2584-98. PubMed ID: 20368345
[TBL] [Abstract][Full Text] [Related]
2. Delineation of regions of the Yersinia YopM protein required for interaction with the RSK1 and PRK2 host kinases and their requirement for interleukin-10 production and virulence.
McPhee JB; Mena P; Bliska JB
Infect Immun; 2010 Aug; 78(8):3529-39. PubMed ID: 20515922
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-10 induction is an important virulence function of the Yersinia pseudotuberculosis type III effector YopM.
McPhee JB; Mena P; Zhang Y; Bliska JB
Infect Immun; 2012 Jul; 80(7):2519-27. PubMed ID: 22547545
[TBL] [Abstract][Full Text] [Related]
4. The yersinia virulence factor YopM forms a novel protein complex with two cellular kinases.
McDonald C; Vacratsis PO; Bliska JB; Dixon JE
J Biol Chem; 2003 May; 278(20):18514-23. PubMed ID: 12626518
[TBL] [Abstract][Full Text] [Related]
5. Uncovering an Important Role for YopJ in the Inhibition of Caspase-1 in Activated Macrophages and Promoting Yersinia pseudotuberculosis Virulence.
Schoberle TJ; Chung LK; McPhee JB; Bogin B; Bliska JB
Infect Immun; 2016 Apr; 84(4):1062-1072. PubMed ID: 26810037
[TBL] [Abstract][Full Text] [Related]
6. The Yersinia Virulence Factor YopM Hijacks Host Kinases to Inhibit Type III Effector-Triggered Activation of the Pyrin Inflammasome.
Chung LK; Park YH; Zheng Y; Brodsky IE; Hearing P; Kastner DL; Chae JJ; Bliska JB
Cell Host Microbe; 2016 Sep; 20(3):296-306. PubMed ID: 27569559
[TBL] [Abstract][Full Text] [Related]
7. Manipulation of pro-inflammatory cytokine production by the bacterial cell-penetrating effector protein YopM is independent of its interaction with host cell kinases RSK1 and PRK2.
Höfling S; Scharnert J; Cromme C; Bertrand J; Pap T; Schmidt MA; Rüter C
Virulence; 2014; 5(7):761-71. PubMed ID: 25513777
[TBL] [Abstract][Full Text] [Related]
8. Immunosuppressive Yersinia Effector YopM Binds DEAD Box Helicase DDX3 to Control Ribosomal S6 Kinase in the Nucleus of Host Cells.
Berneking L; Schnapp M; Rumm A; Trasak C; Ruckdeschel K; Alawi M; Grundhoff A; Kikhney AG; Koch-Nolte F; Buck F; Perbandt M; Betzel C; Svergun DI; Hentschke M; Aepfelbacher M
PLoS Pathog; 2016 Jun; 12(6):e1005660. PubMed ID: 27300509
[TBL] [Abstract][Full Text] [Related]
9. Toward a molecular pathogenic pathway for Yersinia pestis YopM.
Uittenbogaard AM; Chelvarajan RL; Myers-Morales T; Gorman AA; Brickey WJ; Ye Z; Kaplan AM; Cohen DA; Ting JP; Straley SC
Front Cell Infect Microbiol; 2012; 2():155. PubMed ID: 23248776
[TBL] [Abstract][Full Text] [Related]
10. The plague virulence protein YopM targets the innate immune response by causing a global depletion of NK cells.
Kerschen EJ; Cohen DA; Kaplan AM; Straley SC
Infect Immun; 2004 Aug; 72(8):4589-602. PubMed ID: 15271919
[TBL] [Abstract][Full Text] [Related]
11. Yersinia virulence factor YopM induces sustained RSK activation by interfering with dephosphorylation.
Hentschke M; Berneking L; Belmar Campos C; Buck F; Ruckdeschel K; Aepfelbacher M
PLoS One; 2010 Oct; 5(10):. PubMed ID: 20957203
[TBL] [Abstract][Full Text] [Related]
12. Application of a Saccharomyces cerevisiae model to study requirements for trafficking of Yersinia pestis YopM in eucaryotic cells.
Skrzypek E; Myers-Morales T; Whiteheart SW; Straley SC
Infect Immun; 2003 Feb; 71(2):937-47. PubMed ID: 12540576
[TBL] [Abstract][Full Text] [Related]
13. IQGAP1 is important for activation of caspase-1 in macrophages and is targeted by Yersinia pestis type III effector YopM.
Chung LK; Philip NH; Schmidt VA; Koller A; Strowig T; Flavell RA; Brodsky IE; Bliska JB
mBio; 2014 Jul; 5(4):e01402-14. PubMed ID: 24987096
[TBL] [Abstract][Full Text] [Related]
14. The proinflammatory response induced by wild-type Yersinia pseudotuberculosis infection inhibits survival of yop mutants in the gastrointestinal tract and Peyer's patches.
Logsdon LK; Mecsas J
Infect Immun; 2006 Mar; 74(3):1516-27. PubMed ID: 16495522
[TBL] [Abstract][Full Text] [Related]
15. Contribution of the major secreted yops of Yersinia enterocolitica O:8 to pathogenicity in the mouse infection model.
Trülzsch K; Sporleder T; Igwe EI; Rüssmann H; Heesemann J
Infect Immun; 2004 Sep; 72(9):5227-34. PubMed ID: 15322017
[TBL] [Abstract][Full Text] [Related]
16. Caspase-3 mediates the pathogenic effect of Yersinia pestis YopM in liver of C57BL/6 mice and contributes to YopM's function in spleen.
Ye Z; Gorman AA; Uittenbogaard AM; Myers-Morales T; Kaplan AM; Cohen DA; Straley SC
PLoS One; 2014; 9(11):e110956. PubMed ID: 25372388
[TBL] [Abstract][Full Text] [Related]
17. TyeA of Yersinia pseudotuberculosis is involved in regulation of Yop expression and is required for polarized translocation of Yop effectors.
Sundberg L; Forsberg A
Cell Microbiol; 2003 Mar; 5(3):187-202. PubMed ID: 12614462
[TBL] [Abstract][Full Text] [Related]
18. Distinct CCR2(+) Gr1(+) cells control growth of the Yersinia pestis ΔyopM mutant in liver and spleen during systemic plague.
Ye Z; Uittenbogaard AM; Cohen DA; Kaplan AM; Ambati J; Straley SC
Infect Immun; 2011 Feb; 79(2):674-87. PubMed ID: 21149593
[TBL] [Abstract][Full Text] [Related]
19. Intranasal inoculation of mice with Yersinia pseudotuberculosis causes a lethal lung infection that is dependent on Yersinia outer proteins and PhoP.
Fisher ML; Castillo C; Mecsas J
Infect Immun; 2007 Jan; 75(1):429-42. PubMed ID: 17074849
[TBL] [Abstract][Full Text] [Related]
20. Molecular analysis of a novel Toll/interleukin-1 receptor (TIR)-domain containing virulence protein of Y. pseudotuberculosis among Far East scarlet-like fever serotype I strains.
Nörenberg D; Wieser A; Magistro G; Hoffmann C; Meyer C; Messerer M; Schubert S
Int J Med Microbiol; 2013 Dec; 303(8):583-94. PubMed ID: 24018301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
